Kari Kale, MD
Internal Medicine · Billings, MTNPI 1285746693
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $83,300 of the $83,300 with a category attached, or 100.0%. Reporting peaked in 2019 at $34,400 and has fallen 52.0% since, to $16,500 in 2021. Among internal medicine clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 32 payments — averaging $2603.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$49K
- Shire North American Group Inc$34K
What the payments were for
- Consulting fees$83,300100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $48,900 |
| Shire North American Group Inc | 14 | $34,400 |
How this compares
$83,300 in reported general payments places this provider in the 95th percentile of 244 internal medicine providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 271 | $271,204 |
| OzempicSemaglutide | 130 | $140,935 |
| JardianceEmpagliflozin | 107 | $132,058 |
| MounjaroTirzepatide | 79 | $84,138 |
| TrulicityDulaglutide | 62 | $61,569 |
| XareltoRivaroxaban | 46 | $54,666 |
| Repatha SureclickEvolocumab | 76 | $49,761 |
| Tresiba Flextouch U-100Insulin Degludec | 41 | $33,071 |
| Emgality PenGalcanezumab-Gnlm | 41 | $29,758 |
| MyrbetriqMirabegron | 36 | $27,896 |
| RybelsusSemaglutide | 25 | $27,688 |
| Repatha SyringeEvolocumab | 24 | $26,465 |
| Spiriva HandihalerTiotropium Bromide | 25 | $23,707 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $23,437 |
| Spiriva RespimatTiotropium Bromide | 32 | $23,014 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Billings
- Joseph PeilaBillings$148K
- Tracy RauschBillings$11K
- Brian HessBillings$8K
- Jessica HogeBillings$4K
- Justen RudolphBillings$2K
- Michael MetzgerBillings$1K
- Lucinda HusbyBillings$659
- Michael HaganBillings$261
- Faranak ArganiBillings$220
- Hayley MillerMissoula$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.